Enterprise of Rosatom State Corporation
Print version

Industry news

04/02/2014

Clinical Comparison of Tc-99m Exametazime and I-123 Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury

Researchers are seeking to understand what happens inside the living brain after a concussion. In a study published today in PLOS ONE, researchers at Thomas Jefferson University used SPECT to evaluate two ways to measure physiological brain activity in Traumatic Brain Injury (T.B.I.) patients with chronic, mild symptoms. The findings of their blinded, case-control study are published in an article entitled «Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury». The study included 25 cases and 10 controls.

For more information visit: www.itnonline.com

 


comments powered by Disqus